Cannabis stocks surged as the DEA plans to reclassify marijuana, easing restrictions and acknowledging its medicinal benefits. Canopy Growth, Village Farms, and AdvisorShares Pure Cannabis ETF shares soared. This move would mark cannabis as a Schedule III drug, acknowledging its medical benefits and potentially paving the way for federal legalization. The DEA’s decision awaits White House review.
Read the full story here
Written by: mfox@businessinsider.com (Matthew Fox)
Published on May 1, 2024 at 05:08AM
Source: Business Insider (opens in new tab)